# Hemo Organic (NSE: HEMORGANIC) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/HEMORGANIC · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹7 Cr, it ranks 3993rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Capital Goods sector; its industry is Conglomerates.

Its return on equity was −108.2% in FY25.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹7 Cr |
| ROE | −108.2% (FY25) |
| ROCE | 1.9% (FY25) |
| Debt to equity | -9.77 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹2 Cr | ₹0 Cr |
| FY24 | ₹0 Cr | −₹0 Cr |
| FY23 | ₹0 Cr | −₹0 Cr |
| FY22 | ₹0 Cr | −₹0 Cr |
| FY21 | ₹0 Cr | −₹0 Cr |
| FY20 | ₹0 Cr | −₹0 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Jonjua Overseas](https://app.pivotnow.in/stock/JONJUA) | — | ₹9 Cr | — | — |
| [Harig Crankshaf](https://app.pivotnow.in/stock/HARCR) | — | ₹8 Cr | — | — |
| [Premier](https://app.pivotnow.in/stock/PREMIER) | ₹2.66 | ₹8 Cr | — | — |
| [Incon Engineers](https://app.pivotnow.in/stock/INCON) | — | ₹7 Cr | — | — |
| [Parker Agro](https://app.pivotnow.in/stock/PARKERAC) | — | ₹7 Cr | — | — |
| [Amraworld](https://app.pivotnow.in/stock/AMRAAGRI) | — | ₹6 Cr | — | — |

## Questions and answers

### What is the market cap of Hemo Organic?

Hemo Organic's market capitalisation is ₹7 Cr (₹7 Cr) at the 19 Oct 2026 close, ranking 3993rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Hemo Organic?

Return on equity was −108.2% in FY25 and return on capital employed was 1.9% in FY25 (standalone figures).

### Is Hemo Organic a debt-free company?

Hemo Organic is close to debt-free: its debt-to-equity ratio was -9.77 in FY25.

### Who are Hemo Organic's competitors?

The listed Capital Goods companies closest to Hemo Organic by market cap are Jonjua Overseas, Harig Crankshaf, Premier, Incon Engineers, Parker Agro and Amraworld.

### Is Hemo Organic a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Hemo Organic's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on HEMORGANIC against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.